Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alex Cole
CDK4/6 Inhibition as Maintenance and Combination Therapy for High Grade Serous Ovarian Cancer
Oncotarget
Oncology
Related publications
Targeting IDH1 as a Pro-Senescent Therapy in High-Grade Serous Ovarian Cancer
Molecular Cancer Research
Cancer Research
Oncology
Molecular Biology
New in High Grade Serous Ovarian Cancer Treatment
Effective Pharmacotherapy
Nadir CA-125 Level as Prognosis Indicator of High-Grade Serous Ovarian Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
PARP Inhibitors in Platinum-Sensitive High-Grade Serous Ovarian Cancer
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
CBX2 Identified as Driver of Anoikis Escape and Dissemination in High Grade Serous Ovarian Cancer
Oncogenesis
Cancer Research
Molecular Biology
Low-Stage High-Grade Serous Ovarian Carcinomas
International Journal of Gynecological Pathology
Gynecology
Forensic Medicine
Pathology
Obstetrics
Molecular Abnormalities in Ovarian Cancer Subtypes Other Than High-Grade Serous Carcinoma
Journal of Oncology
Oncology
Proteome Profiling of Low Grade Serous Ovarian Cancer
Journal of Ovarian Research
Gynecology
Oncology
Obstetrics
High-Grade Serous Carcinoma Resulting From Rectal Endometriosis and Complicated With Ovarian Cancer
Frontiers in Oncology
Cancer Research
Oncology